arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Surgery Partners, Inc.

SGRY
$14.56 ▼ -1.22 (-7.73%) at close
Healthcare ·Services-General Medical & Surgical Hospitals, NEC ·USServices-General Medical & Surgical Hospitals, NEC
47 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
35
Health
Weak
Bearish
auto_awesome

Analytical Summary

Surgery Partners, Inc. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $1.9B
Dividend Yield
Revenue Growth 2.7%
Op. Margin 12.0%
ROIC 4.8%
FCF / Share $0.29
Trailing P/E
Price / Book 1.1x
FCF Yield 2.0%
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

47-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$848.90M
↑ +2.7%
Net Income Profit after all expenses
$-15.00M
↓ -500.0%
Operating Margin Operating profit as % of sales
12.0%
↑ +48.2% 60th
FCF / Share Free cash flow per share
$0.29
↑ +969.0%
Long-Term Debt Long-term obligations
$3.74B
↑ +33.2%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Profitability
45
Returns
39
Financial Health
34
Cash Quality
6

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 13 years · 47 quarters